Latest / Connected With Latham
Episode 128 – Drug Pricing and Market Access: Takeaways from the Medicaid Drug Rebate Program Summit 2026
Stakeholders from across the healthcare industry recently convened in Chicago for the Medicaid Drug Rebate Program Summit 2026. In this episode of Connected With Latham, Washington, D.C. partner Chris Schott discusses key takeaways from the conference with Amanda Forys, Managing Partner at Magnolia Market Access, and Sabrina Aery, Founder at Aery Policy & Access Partners. Topics include Most Favored Nation pricing developments, the evolving 340B landscape, Average Sales Price reporting, and the implementation of the Inflation Reduction Act.
Also check out our bi-weekly Drug Pricing Digest on…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.